Literature DB >> 17194657

Mucormycosis in a patient with low risk myelodysplasia treated with anti-TNF-alpha.

A Keijzer1, P van der Valk, G J Ossenkoppele, A A van de Loosdrecht.   

Abstract

Accelerated programmed cell death or apoptosis appears to play an important role in the pathogenesis of myelodysplasia. As overexpression of TNF-alpha has been described to induce cell death in myelodysplasia, treatment with anti-TNF-alpha is currently being explored. Caution is needed because of an increased risk of opportunistic infection during anti-TNF-alpha treatment. We here describe a patient who was treated with anti-TNF-alpha for low risk myelodysplasia and died of invasive mucormycosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17194657

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  4 in total

Review 1.  Infections in myelodysplastic syndromes.

Authors:  Andréa Toma; Pierre Fenaux; François Dreyfus; Catherine Cordonnier
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

2.  A Unique Case of Intracranial Mucormycosis Following an Assault.

Authors:  Fadilah S Hussain; Namath S Hussain
Journal:  Cureus       Date:  2016-07-17

3.  Successful Treatment of Primary Cutaneous Mucormycosis Complicating Anti-TNF Therapy with a Combination of Surgical Debridement and Oral Posaconazole.

Authors:  Jose F Camargo; Danny Yakoub; Jeong Hee Cho-Vega
Journal:  Mycopathologia       Date:  2015-06-26       Impact factor: 2.574

Review 4.  COVID-19-associated opportunistic infections: a snapshot on the current reports.

Authors:  Amir Abdoli; Shahab Falahi; Azra Kenarkoohi
Journal:  Clin Exp Med       Date:  2021-08-23       Impact factor: 5.057

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.